PTC Therapeutics, Inc. (PTCT) ROI
- 2026-06-30: ROI -9.02%.
- 2022-06-30: ROI -222.15%.
- 2022-03-31: ROI -152.93%.
- 2021-12-31: ROI -121.03%.
Complete source-backed roi history.
- Available history
- 2012-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|
| 2026-06-30 | -9.02% |
|---|
| 2022-06-30 | -222.15% |
|---|
| 2022-03-31 | -152.93% |
|---|
| 2021-12-31 | -121.03% |
|---|
| 2021-09-30 | -84.90% |
|---|
| 2020-09-30 | -54.24% |
|---|
| 2020-06-30 | -48.63% |
|---|
| 2020-03-31 | -34.64% |
|---|
| 2019-12-31 | -27.70% |
|---|
| 2019-09-30 | -22.75% |
|---|
| 2019-06-30 | -33.09% |
|---|
| 2019-03-31 | -27.08% |
|---|
| 2018-12-31 | -25.43% |
|---|
| 2018-09-30 | -14.61% |
|---|
| 2018-06-30 | -14.71% |
|---|
| 2017-12-31 | -26.21% |
|---|
Annual ROI
| Date | ROI |
|---|
| 2021-12-31 | -121.03% |
|---|
| 2019-12-31 | -27.70% |
|---|
| 2018-12-31 | -25.43% |
|---|
| 2017-12-31 | -26.21% |
|---|
| 2012-12-31 | 27.69% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|